GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.75
+0.05 (0.28%)
At close: Feb 11, 2026

TPE:3164 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
391.48385.37318.02368.55427.93325.19
Revenue Growth (YoY)
6.23%21.18%-13.71%-13.88%31.59%-6.08%
Cost of Revenue
155.7147.19106.82111.83128.6109.8
Gross Profit
235.77238.18211.19256.72299.33215.39
Selling, General & Admin
148.14152.79156.6137.12145.47118.73
Research & Development
44.6645.2746.8659.4125.5226.3
Operating Expenses
191.83197.55204.2194.75174.29144.42
Operating Income
43.9440.636.9961.97125.0470.97
Interest Expense
-4.09-3.72-0.97-0.76-0.77-0.81
Interest & Investment Income
8.6411.69.464.82.352.89
Earnings From Equity Investments
------0.1
Currency Exchange Gain (Loss)
-17.3117.05-6.9810.45-1.35-1.34
Other Non Operating Income (Expenses)
1.080.40.34-1.981.060.82
EBT Excluding Unusual Items
32.2765.978.8374.48126.3472.44
Gain (Loss) on Sale of Investments
3.48-1.2319.05-8.169.35-3.32
Gain (Loss) on Sale of Assets
-0.02-0.020.28-0.063.740.24
Other Unusual Items
-----7.49
Pretax Income
35.7364.7228.1666.26139.4276.85
Income Tax Expense
10.2316.975.7318.829.8216.63
Earnings From Continuing Operations
25.4947.7522.4347.46109.660.22
Net Income to Company
25.4947.7522.4347.46109.660.22
Minority Interest in Earnings
99.510.569.523.530.67
Net Income
34.4957.2532.9956.98113.1360.88
Net Income to Common
34.4957.2532.9956.98113.1360.88
Net Income Growth
-35.10%73.53%-42.10%-49.64%85.82%5.98%
Shares Outstanding (Basic)
868786868688
Shares Outstanding (Diluted)
878787878788
Shares Change (YoY)
-0.09%0.18%-0.10%-0.09%-1.50%-1.34%
EPS (Basic)
0.400.660.380.661.310.69
EPS (Diluted)
0.390.660.380.661.300.69
EPS Growth
-36.53%73.68%-42.40%-49.25%88.41%7.81%
Free Cash Flow
89.4979.891.2965.79-5.28-20.5
Free Cash Flow Per Share
1.030.920.010.76-0.06-0.23
Dividend Per Share
0.8000.8000.5000.7001.1000.700
Dividend Growth
60.00%60.00%-28.57%-36.36%57.14%-12.50%
Gross Margin
60.23%61.80%66.41%69.66%69.95%66.23%
Operating Margin
11.22%10.54%2.20%16.81%29.22%21.82%
Profit Margin
8.81%14.86%10.37%15.46%26.44%18.72%
Free Cash Flow Margin
22.86%20.73%0.41%17.85%-1.23%-6.30%
EBITDA
107.55108.1868.77109.92143.0588.77
EBITDA Margin
27.47%28.07%21.63%29.82%33.43%27.30%
D&A For EBITDA
63.6167.5561.7947.9518.0217.8
EBIT
43.9440.636.9961.97125.0470.97
EBIT Margin
11.22%10.54%2.20%16.81%29.22%21.82%
Effective Tax Rate
28.64%26.22%20.35%28.37%21.39%21.64%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.